The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

The results were quite surprising. They found that people who took GLP-1 agonists had a 30% lower risk of developing dementia ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Older diabetes medications known as thiazolidinediones (TZDs) may slow prostate cancer progression, new research indicates.

These drugs are commonly prescribed to help control blood sugar levels in people with type 2 diabetes. While they have been ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

A class of older drugs used to treat type 2 diabetes may also help slow the progression of prostate cancer, a small study ...

A recent study led by scientists at the University of Florida suggests that two classes of diabetes drugs—GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is)—could lower the risk ...

The following is a summary of “Investigating socioeconomic disparities in prescribing new diabetes medications in individuals ...